These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2031258)
81. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function. Barenbrock M; Colmorgen U; Firschka E; Gellert J; Lippert J; Schröder K; Spieker C; Voigt-Ladner G; Wagner K; Neumayer HH Clin Nephrol; 1995 Jun; 43(6):388-91. PubMed ID: 7554523 [TBL] [Abstract][Full Text] [Related]
82. Pharmacokinetics of everolimus when combined with cyclosporine in Japanese de novo renal transplant recipients. Uchida K; Hoshinaga K; Watarai Y; Goto N; Kusaka M; Sasaki H; Hirano M; Transplant Proc; 2014 Jun; 46(5):1314-8. PubMed ID: 24935294 [TBL] [Abstract][Full Text] [Related]
83. Evaluation of cyclosporine C2 levels in long-term stable renal allograft recipients. Hu RH; Tsai MK; Lee PH Transplant Proc; 2004 Sep; 36(7):2105-7. PubMed ID: 15518762 [TBL] [Abstract][Full Text] [Related]
84. The effect of pregnancy on cyclosporine levels in renal allograft patients. Thomas AG; Burrows L; Knight R; Panico M; Lapinski R; Lockwood CJ Obstet Gynecol; 1997 Dec; 90(6):916-9. PubMed ID: 9397102 [TBL] [Abstract][Full Text] [Related]
85. Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report. Nakagita K; Wada K; Terada Y; Matsuda S; Terakawa N; Oita A; Takada M Int J Clin Pharmacol Ther; 2018 Jun; 56(6):270-276. PubMed ID: 29648533 [TBL] [Abstract][Full Text] [Related]
86. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172 [TBL] [Abstract][Full Text] [Related]
87. Increased cyclosporine blood concentrations due to verapamil administration. Maggio TG; Bartels DW Drug Intell Clin Pharm; 1988 Sep; 22(9):705-7. PubMed ID: 3063481 [TBL] [Abstract][Full Text] [Related]
89. Relationships of cyclosporine concentrations in serum, whole blood, and bile after renal and hepatic transplantation. Vine W; Flye MW; Jatlow P Clin Chem; 1986 Oct; 32(10):1828-31. PubMed ID: 3530529 [TBL] [Abstract][Full Text] [Related]
90. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients. Rosano TG Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273 [TBL] [Abstract][Full Text] [Related]
91. Determination of cyclosporine concentrations with monoclonal antibodies. Schran HF; Rosano TG; Hassell AE; Pell MA Clin Chem; 1987 Dec; 33(12):2225-9. PubMed ID: 3319290 [TBL] [Abstract][Full Text] [Related]
92. Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients. Trull A; Hue K; Tan K; Gore S; Whitewood S; Smyth R; Scott J; Price C; Wallwork J Clin Chem; 1990 Aug; 36(8 Pt 1):1474-8. PubMed ID: 2387045 [TBL] [Abstract][Full Text] [Related]
93. Dose-dependent inhibition of cyclosporine metabolism in mice by fluconazole. La Delfa I; Xia YF; Blaschke TF Can J Physiol Pharmacol; 1990 Jan; 68(1):89-93. PubMed ID: 2328446 [TBL] [Abstract][Full Text] [Related]
94. Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker rat. Berens KL; Vadiei K; Brunner LJ; Wasan KM; Luke DR Biopharm Drug Dispos; 1990 Apr; 11(3):197-206. PubMed ID: 2328306 [TBL] [Abstract][Full Text] [Related]
95. Distribution of cyclosporine in blood of a renal-transplant recipient with type V hyperlipoproteinemia. Verrill HL; Girgis RE; Easterling RE; Malhi BS; Mueller WF Clin Chem; 1987 Mar; 33(3):423-8. PubMed ID: 3545541 [TBL] [Abstract][Full Text] [Related]
96. The effect of ethanol on serum cyclosporine A levels in renal transplant recipients. Paul MD; Parfrey PS; Smart M; Gault H Am J Kidney Dis; 1987 Aug; 10(2):133-5. PubMed ID: 3300294 [TBL] [Abstract][Full Text] [Related]
97. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit. Yee GC; McGuire TR; Gmur DJ; Lennon TP; Deeg HJ Transplantation; 1988 Sep; 46(3):399-402. PubMed ID: 3047931 [TBL] [Abstract][Full Text] [Related]
98. Association of the absence of steroid therapy with increased cyclosporine blood levels in renal transplant recipients. Hricik DE; Moritz C; Mayes JT; Schulak JA Transplantation; 1990 Jan; 49(1):221-3. PubMed ID: 2301016 [No Abstract] [Full Text] [Related]
99. Serum alpha-2-macroglobulin, antitrypsin and antichymotrypsin activities in patients receiving treatment with cyclosporine. Roche M; Kusumanjali G; Reddy GC; Kanagasabhapathy AS; Rao P Indian J Clin Biochem; 2006 Sep; 21(2):63-6. PubMed ID: 23105616 [TBL] [Abstract][Full Text] [Related]
100. Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive study. Tecen-Yucel K; Bayraktar-Ekincioglu A; Yıldırım T; Demirkan K; Erdem Y Eur J Hosp Pharm; 2024 Oct; 31(6):560-563. PubMed ID: 37236776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]